Leona Holmberg

Leona Holmberg

UNVERIFIED PROFILE

Are you Leona Holmberg?   Register this Author

Register author
Leona Holmberg

Leona Holmberg

Publications by authors named "Leona Holmberg"

Are you Leona Holmberg?   Register this Author

82Publications

2621Reads

41Profile Views

Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life.

Biol Blood Marrow Transplant 2019 Oct 9. Epub 2019 Oct 9.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Medicine/Medical Oncology, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.10.002DOI Listing
October 2019

Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma.

Clin Cancer Res 2019 Sep 3. Epub 2019 Sep 3.

Department of Medicine, University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-1567DOI Listing
September 2019

Bortezomib and Vorinostat Therapy as Maintenance Therapy after Autologous Transplant for Multiple Myeloma.

Acta Haematol 2019 Aug 21:1-9. Epub 2019 Aug 21.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000501298DOI Listing
August 2019

Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy.

Biol Blood Marrow Transplant 2018 07 1;24(7):1386-1391. Epub 2018 Mar 1.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington; Seattle Cancer Care Alliance, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183010
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.02.017DOI Listing
July 2018

Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell Lymphoma.

Biol Blood Marrow Transplant 2018 02 20;24(2):282-287. Epub 2017 Oct 20.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791173079
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2017.10.029DOI Listing
February 2018

Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin.

Acta Haematol 2017 30;137(3):123-131. Epub 2017 Mar 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000455937DOI Listing
July 2017

Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance Therapies.

Biol Blood Marrow Transplant 2017 Mar 28;23(3):505-511. Epub 2016 Dec 28.

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.12.620DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373666PMC
March 2017

Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma.

Biol Blood Marrow Transplant 2016 09 14;22(9):1582-1587. Epub 2016 Jun 14.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.06.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981519PMC
September 2016

Panobinostat: a review of trial results and future prospects in multiple myeloma.

Expert Rev Hematol 2015 Feb 20;8(1):9-18. Epub 2014 Nov 20.

University of Washington School of Medicine - Medical Oncology, 825 Eastlake Ave E, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2015.983065DOI Listing
February 2015

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.

J Clin Oncol 2014 Feb 16;32(4):273-81. Epub 2013 Dec 16.

Timothy S. Fenske and Mehdi Hamadani, Medical College of Wisconsin; Mei-Jie Zhang, Jeanette Carreras, and Parameswaran N. Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; Ernesto Ayala, H. Lee Moffitt Cancer Center and Research Institute, Tampa; Baldeep M. Wirk, Shands Healthcare and University of Florida, Gainesville, FL; Linda J. Burns, University of Minnesota Medical Center, Fairview, Minneapolis; David J. Inwards, Mayo Clinic Rochester, Rochester, MN; Amanda Cashen, Barnes Jewish Hospital, Washington University School of Medicine, St. Louis, MO; Luciano J. Costa, Medical University of South Carolina, Charleston, SC; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center, San Antonio, TX; Robert P. Gale, Imperial College; Silvia Montoto, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; Leona A. Holmberg and David G. Maloney, Fred Hutchinson Cancer Research Center, Seattle, WA; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Reinhold Munker, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA; Miguel-Angel Perales, Memorial Sloan-Kettering Cancer Center, New York, NY; David A. Rizzieri, Duke University Medical Center, Durham, NC; Harry C. Schouten, Academische Ziekenhuis Maastricht, Maastricht, the Netherlands; Sonali M. Smith, University of Chicago Hospitals, Chicago, IL; Edmund K. Waller, Emory University Hospital, Atlanta, GA; and Ginna G. Laport, Stanford Hospital and Clinics, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.2454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897255PMC
February 2014

The effective use of plerixafor as a real-time rescue strategy for patients poorly mobilizing autologous CD34(+) cells.

J Clin Apher 2012 2;27(2):81-7. Epub 2012 Feb 2.

Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jca.21206
Publisher Site
http://dx.doi.org/10.1002/jca.21206DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004340PMC
August 2012

The role of autologous and allogeneic hematopoietic stem cell transplantation for Hodgkin lymphoma.

J Natl Compr Canc Netw 2011 Sep;9(9):1060-71

Fred Hutchinson Cancer Research Center, Seattle, Washington 98104-1029, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207964PMC
http://dx.doi.org/10.6004/jnccn.2011.0087DOI Listing
September 2011

Busulfan in hematopoietic stem cell transplant setting.

Expert Opin Drug Metab Toxicol 2009 Aug;5(8):957-69

University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue, P.O. Box 19024, Mailstop G7-405, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425250903107764DOI Listing
August 2009

High-dose chemotherapy with BEAM or Busulphan/Melphalan and Thiotepa followed by hematopoietic cell transplantation in malignant lymphoma.

Leuk Lymphoma 2008 Oct;49(10):1899-906

Akademia Medyczna w Gdansku, 80-210 Gdansk, ul. M., Sklodowskiej-Curie 3a, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802340184DOI Listing
October 2008

Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium.

Gynecol Oncol 2008 Aug 6;110(2):146-51. Epub 2008 Jun 6.

Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.04.037DOI Listing
August 2008

Immunotherapy with rituximab/interleukin-2 after autologous stem cell transplantation as treatment for CD20+ non-Hodgkin's lymphoma.

Clin Lymphoma Myeloma 2006 Sep;7(2):135-9

Clinical Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2006.n.051DOI Listing
September 2006

Revisiting the role of dose intensity in hematological malignancies.

Exp Hematol 2006 Jul;34(7):811-25

Fred Hutchinson Cancer Research Center, Clinical Division, and University of Washington School of Medicine, Department of Medicine, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2006.04.014DOI Listing
July 2006

Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome.

Biol Blood Marrow Transplant 2006 Feb;12(2):226-34

Medical Oncology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387910500681
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2005.10.011DOI Listing
February 2006

Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies.

Int J Radiat Oncol Biol Phys 2006 Jan 19;64(1):227-34. Epub 2005 Sep 19.

Fred Hutchinson Cancer Research Center, University of Washington, Clinical Research Division, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.06.005DOI Listing
January 2006

Dose escalation of busulfan with pentoxifylline and ciprofloxacin in patients with breast cancer undergoing autologous transplants.

Oncology 2004 ;67(5-6):368-75

Fred Hutchinson Cancer Research Center, and University of Washington School of Medicine Seattle, Wash., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000082920DOI Listing
February 2005

Vaccination with Theratope (STn-KLH) as treatment for breast cancer.

Expert Rev Vaccines 2004 Dec;3(6):655-63

University of Washington School of Medicine, Department of Medicine, and Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N. PO Box 19024, D5-390, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14760584.3.6.655
Publisher Site
http://dx.doi.org/10.1586/14760584.3.6.655DOI Listing
December 2004

Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.

Leuk Res 2004 Nov;28(11):1177-80

Division of Clinical Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., D1-100, PO Box 19024, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2004.03.016DOI Listing
November 2004

Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation.

Blood 2004 Sep 29;104(6):1894-7. Epub 2004 Apr 29.

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Human Immunogenetics Program, 1100 Fairview Ave N, D2-100, PO Box 19024, Seattle, WA 98109-19024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-02-0508DOI Listing
September 2004

Vaccination as a treatment for breast or ovarian cancer.

Expert Rev Vaccines 2004 Jun;3(3):269-77

Department of Medicine, University of Washington School of Medicine, and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14760584.3.3.269
Publisher Site
http://dx.doi.org/10.1586/14760584.3.3.269DOI Listing
June 2004

Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation.

Biol Blood Marrow Transplant 2002 ;8(5):281-9

Fred Hutchinson Cancer Research Center, Seattle Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
July 2003

Hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.

Oncology (Williston Park) 2003 May;17(5):627-32, 635, 640; discussion 640-2

Clinical Research Division, Fred Hutchinson Cancer Research Center, Department of Medicine, University of Washington, School of Medicine, USA.

View Article

Download full-text PDF

Source
May 2003

The role of cancer vaccines following autologous stem cell rescue in breast and ovarian cancer patients: experience with the STn-KLH vaccine (Theratope).

Clin Breast Cancer 2003 Feb;3 Suppl 4:S144-51

Department of Medicine, University of Washington School of Medicine, and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle 98109-1024, USA.

View Article

Download full-text PDF

Source
February 2003